| Literature DB >> 34220865 |
Thomas Yen-Ting Chen1, Mei-Chia Chou2,3, Jung-Nien Lai4,5, Lu-Ting Chiu6,7, Renin Chang8, Yao-Min Hung9,10,11,12, James Cheng-Chung Wei9,13,14.
Abstract
Objective: The aim of this study was to investigate the relationship between non-typhoidal Salmonella (NTS) infection and the risk of Kawasaki disease (KD) by using a nationwide population-based data set in Taiwan.Entities:
Keywords: Cohort study; Kawasaki disease; NHIRD; Non-typhoidal Salmonella; Taiwan
Mesh:
Year: 2021 PMID: 34220865 PMCID: PMC8252964 DOI: 10.3389/fimmu.2021.701409
Source DB: PubMed Journal: Front Immunol ISSN: 1664-3224 Impact factor: 7.561
Baseline characteristics of patients with and without non-typhoidal Salmonella (NTS) infection.
| Before PS matched | After PS matched | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| NTS | Non-NTS | |||||||||
| No (n=23551857) | Yes (n=73837) | SMD | No (n=276464) | Yes (n=69116) | SMD | |||||
|
|
|
|
|
|
|
|
|
| ||
| ≤2 | 439513 | 8.50 | 36246 | 62.31 | 1.36 | 115653 | 57.34 | 28993 | 57.49 | 0.003 |
| 3-5 | 702791 | 13.60 | 15325 | 26.34 | 0.32 | 59517 | 29.51 | 14833 | 29.41 | 0.002 |
| >5 | 4026926 | 77.90 | 6601 | 11.35 | 1.8 | 26538 | 13.16 | 6601 | 13.09 | 0.002 |
| Mean ± SD | 9.87±5.14 | 2.47±2.75 | 1.79 | 2.71±2.94 | 2.69±2.89 | 0.008 | ||||
|
| ||||||||||
| Female | 2504475 | 48.45 | 25741 | 44.25 | 0.08 | 89350 | 44.30 | 22422 | 44.46 | 0.003 |
| Male | 2664755 | 51.55 | 32431 | 55.75 | 0.08 | 112358 | 55.70 | 28005 | 55.54 | 0.003 |
|
| ||||||||||
| Allergic rhinitis | 18179 | 0.35 | 464 | 0.80 | 0.06 | 817 | 0.41 | 408 | 0.81 | 0.05 |
| Urticaria | 14567 | 0.28 | 389 | 0.67 | 0.06 | 547 | 0.27 | 323 | 0.64 | 0.05 |
| Atopic dermatitis | 53073 | 1.03 | 9712 | 16.70 | 0.57 | 9151 | 4.54 | 1967 | 3.90 | 0.03 |
|
| ||||||||||
| 1 (high) | 1474890 | 28.53 | 15974 | 27.46 | 0.02 | 55460 | 27.50 | 14018 | 27.80 | 0.007 |
| 2 | 1560935 | 30.20 | 18239 | 31.35 | 0.03 | 65780 | 32.61 | 15876 | 31.48 | 0.02 |
| 3 | 991819 | 19.19 | 10428 | 17.93 | 0.03 | 35238 | 17.47 | 9136 | 18.12 | 0.01 |
| 4 (low) | 1141586 | 22.08 | 13531 | 23.26 | 0.03 | 45230 | 22.42 | 11397 | 22.60 | 0.004 |
|
| 7.48±4.00 | 7.02±4.02 | 0.11 | 7.48±4.08 | 7.03±4.03 | 0.11 | ||||
Data shown as n(%) or mean ± SD. SMD, standardized mean difference. A standardized mean difference of ≤ 0.10 indicates a negligible difference between the two groups.
Subgroup analysis.
| Variables | NTS infection | Crude HR(95% CI) | Adjusted HR (95% CI) | p for interaction | |||||
|---|---|---|---|---|---|---|---|---|---|
| No | Yes | ||||||||
| Event | PY | IR | Event | PY | IR | ||||
| Total | 281 | 1510777 | 1.86 | 92 | 354963 | 2.59 | 1.33(1.05-1.68)** | 1.31(1.03-1.66)** | |
|
| 0.97 | ||||||||
| ≤2 | 247 | 863934 | 2.86 | 81 | 211206 | 3.84 | 1.31(1.02-1.68)* | 1.31(1.02-1.69)* | |
| 3-5 | 32 | 453043 | 0.71 | 11 | 99910 | 1.10 | 1.43(0.72-2.83) | 1.45(0.73-2.88) | |
| >5 | 2 | 193799 | 0.10 | 0 | 43845 | 0.00 | -- | -- | |
|
| 0.48 | ||||||||
| Female | 116 | 671523 | 1.73 | 42 | 157371 | 2.67 | 1.47(1.03-2.08)* | 1.46(1.03-2.08)* | |
| Male | 165 | 839253 | 1.97 | 50 | 197591 | 2.53 | 1.23(0.90-1.69) | 1.21(0.88-1.66) | |
|
| |||||||||
| Allergic rhinitis | 0.79 | ||||||||
| No | 280 | 1507072 | 1.86 | 91 | 352743 | 2.58 | 1.32(1.05-1.68)* | 1.32(1.04-1.67)* | |
| Yes | 1 | 3704 | 2.70 | 1 | 2219 | 4.51 | 1.76(0.11-28.29) | 3.12(0.16-38.56) | |
| Urticaria | 0.99 | ||||||||
| No | 281 | 1507936 | 1.86 | 92 | 352890 | 2.61 | 1.33(1.05-1.69)* | 1.31(1.04-1.66)* | |
| Yes | 0 | 2840 | 0.00 | 0 | 2073 | 0.00 | -- | -- | |
| Atopic dermatitis | 0.42 | ||||||||
| No | 275 | 1451590 | 1.89 | 89 | 342342 | 2.60 | 1.30(1.02-1.65)* | 1.31(1.03-1.67)* | |
| Yes | 6 | 59186 | 1.01 | 3 | 12620 | 2.38 | 2.32(0.58-9.26) | 2.51(0.61-10.35) | |
|
| 0.96 | ||||||||
| 1 (high) | 89 | 406387 | 2.19 | 29 | 98476 | 2.94 | 1.30(0.86-1.98) | 1.31(0.86-1.99) | |
| 2 | 79 | 479862 | 1.65 | 23 | 109533 | 2.10 | 1.21(0.76-1.93) | 1.17(0.73-1.86) | |
| 3 | 49 | 270010 | 1.81 | 17 | 65090 | 2.61 | 1.37(0.78-2.37) | 1.39(0.80-2.42) | |
| 4 (low) | 64 | 354517 | 1.81 | 23 | 81862 | 2.81 | 1.45(0.90-2.34) | 1.42(0.89-2.32) | |
|
| 281 | 1510777 | 1.86 | 92 | 354963 | 2.59 | 1.33(1.05-1.68)** | 1.31(1.03-1.66)** | |
*p < 0.05, **p < 0.01.
PY, person-years; IR, incidence rate, per 10,000 person-years; HR, hazard ratio; CI, confidence interval; HR adjusted for age, sex, allergic rhinitis, urticarial, atopic dermatitis and urbanization.
Sensitivity analysis (Model 2).
| Variables | Model 1 + KD coded by pediatric specialists (n=313) | Crude HR (95% CI) | Adjusted HR(95% CI) | ||
|---|---|---|---|---|---|
| Event | PY | IR | |||
|
| |||||
| No | 239 | 1511144 | 1.58 | 1(reference) | 1(reference) |
| Yes | 74 | 355103 | 2.08 | 1.26(0.98-1.64) | 1.35(0.96-1.62) |
PY, person-years; IR, incidence rate, per 10,000 person-years; HR, hazard ratio; CI, confidence interval; HR adjusted for age, sex, allergic rhinitis, urticarial, atopic dermatitis and urbanization.
Sensitivity analysis (Model 3).
| Variables | Model 2 + KD coded in the Registry for Catastrophic Illness Patient Database (n=98) | Crude HR (95% CI) | Adjusted HR(95% CI) | ||
|---|---|---|---|---|---|
| Event | PY | IR | |||
|
| |||||
| No | 71 | 1512137 | 0.47 | 1(reference) | 1(reference) |
| Yes | 27 | 355434 | 0.76 | 1.55(1.01-2.41)* | 1.54(1.00-2.40)* |
*p < 0.05.
PY, person-years; IR, incidence rate, per 10,000 person-years; HR, hazard ratio; CI, confidence interval; HR adjusted for age, sex, allergic rhinitis, urticarial, atopic dermatitis and urbanization.
Alternative outcome analysis.
| Variables | Henoch–Schönlein purpura (n=189) | Crude HR (95% CI) | Adjusted HR(95% CI) | ||
|---|---|---|---|---|---|
| Event | PY | IR | |||
|
| |||||
| No | 151 | 1553622 | 0.97 | 1(reference) | 1(reference) |
| Yes | 38 | 366264 | 1.04 | 1.05(0.74-1.50) | 1.04(0.73-1.49) |
PY, person-years; IR, incidence rate, per 10,000 person-years; HR, hazard ratio; CI, confidence interval; HR adjusted for age, sex, allergic rhinitis, urticarial, atopic dermatitis and urbanization.
Figure 1Cumulative risk of Kawasaki disease in patients with and without non-typhoidal Salmonella infection.
The incidence rate of KD in different factors.
| Variables | Kawasaki disease (n=373) | Crude HR (95% CI) | Adjusted HR (95% CI) | ||
|---|---|---|---|---|---|
| Event | PY | IR | |||
|
| |||||
| No | 281 | 1510777 | 1.86 | 1(reference) | 1(reference) |
| Yes | 92 | 354963 | 2.59 | 1.33(1.05-1.68)** | 1.31(1.03-1.66)** |
|
| |||||
| ≤2 | 328 | 1075141 | 3.05 | 1(reference) | 1(reference) |
| 3-5 | 43 | 552953 | 0.78 | 0.25(0.18-0.35)*** | 0.24(0.18-0.34)*** |
| >5 | 2 | 237645 | 0.08 | 0.02(0.007-0.10)*** | 0.03(0.006-0.10)*** |
|
| |||||
| Female | 158 | 828894 | 1.91 | 1(reference) | 1(reference) |
| Male | 215 | 1036845 | 2.07 | 1.08(0.88-1.33) | 1.12(0.92-1.38) |
|
| |||||
| Allergic rhinitis | |||||
| No | 371 | 1859816 | 1.99 | 1(reference) | 1(reference) |
| Yes | 2 | 5924 | 3.38 | 1.20(0.30-4.82) | 1.99(0.54-6.12) |
| Urticaria | |||||
| No | 373 | 1860827 | 2.00 | 1(reference) | 1(reference) |
| Yes | 0 | 4913 | 0.00 | -- | -- |
| Atopic dermatitis | |||||
| No | 364 | 1793933 | 2.03 | 1(reference) | 1(reference) |
| Yes | 9 | 71807 | 1.25 | 0.55(0.28-1.07) | 1.05(0.58-2.68) |
| Urbanization | |||||
| 1 (high) | 118 | 504863 | 2.34 | 1(reference) | 1(reference) |
| 2 | 102 | 589395 | 1.73 | 0.74(0.57-1.02) | 0.76(0.58-1.03) |
| 3 | 66 | 335101 | 1.97 | 0.87(0.64-1.17) | 0.86(0.63-1.16) |
| 4 (low) | 87 | 436380 | 1.99 | 0.89(0.67-1.17) | 0.90(0.68-1.19) |
**p < 0.01, ***p < 0.001.
PY, person-years; IR, incidence rate, per 10,000 person-years; HR, hazard ratio; CI, confidence interval; HR adjusted for age, sex, allergic rhinitis, urticarial, atopic dermatitis and urbanization.